Mon, 05 Jan 2026

Mon, 05 Jan 2026 First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.

The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.

  >>


Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025